SHANK3 and Alzheimer disease: Moreover, we confirmed the trend of decline in the density of Shank3 IR in the prefrontal, postcentral, and temporal neocortices, the molecular layer of the hippocampal dentate gyrus, and the molecular and granule cell layers of the cerebellar cortex in the adult to the aged group, and, furthermore, to the AD group, relative to the youth group.